Erin’s Stage 3C High Grade Serous Ovarian Cancer Story
Erin shares her personal battle with high grade serous ovarian cancer. Living with her husband and two adult children in New York, she enjoys biking and creating miniatures. Her health journey began with irregular periods and persistent cramping, which she initially attributed to perimenopause. Despite experiencing chronic fatigue and gastrointestinal issues, she did not suspect anything serious until she began bleeding continuously in November 2020.
Interviewed by: Nikki Murphy
Edited by: Chris Sanchez
After consulting various doctors and undergoing numerous tests, Erin opted for a hysterectomy in August 2021. About a week after the procedure, she began experiencing serious symptoms including constipation and severe pain on the lower sides of her back, and had to go to the hospital. She was struggling with these complications when it was revealed that she had extensive stage 3C high grade serous ovarian cancer. Following the diagnosis, Erin advocated for surgery before chemotherapy to assess the cancer stage. She underwent debulking surgery later in November to reduce the size of the tumor when it couldn’t be fully removed, which confirmed the widespread nature of her cancer.
Despite facing severe physical challenges, including a fistula and subsequent hospitalization, Erin remained proactive about her treatment. She researched extensively, consulting peer-reviewed journals and medical experts to make informed decisions. Her insistence on surgery first played a crucial role in her treatment plan.

Erin endured 6 rounds of chemotherapy, facing only one significant adverse reaction. The treatment exacerbated menopausal symptoms, such as hot flashes, but she persevered. By March 2022, Erin completed her chemotherapy, marking her remission with a triumphant bell ring.
Reflecting on her journey, Erin acknowledges areas where she could have improved her health management, such as quitting smoking and maintaining better hydration and exercise routines. She aims to share her story to help others avoid similar mistakes, encouraging them to quit harmful habits for better health outcomes.
Erin’s narrative emphasizes the importance of self-advocacy, thorough research, and persistence in seeking accurate diagnoses and effective treatments. She concludes with an inspiring message: never give up and continue fighting for one’s health, as life holds immeasurable value despite the challenges faced.
- Name:
- Erin R.
- Diagnosis:
- High Grade Serous Ovarian Cancer
- Staging:
- Stage IIIc
- Initial Symptoms:
- Vaginal bleeding
- Multiple gastrointestinal symptoms
- Treatments:
- Surgery
- Chemotherapy
This interview has been edited for clarity and length. This is not medical advice. Please consult with your healthcare provider for treatment decisions.

Inspired by Erin's story?
Share your story, too!
Related Cancer Stories
More Ovarian Cancer Stories
Randalynn V., High-Grade Serous Carcinoma, Stage 1C
Symptoms: Pulling sensation when emptying bladder; abdominal pain
Treatments: Chemotherapy (carboplatin & paclitaxel), surgery
...
Shirley P., High-Grade Serous Carcinoma, Stage 3C, BRCA1+
Symptoms: Pulling sensation when emptying bladder; abdominal pain
Treatments: Chemotherapy (carboplatin & paclitaxel), de-bulking surgery, PARP inhibitors
...
Suzann B., High-Grade Serous Carcinoma, Stage 3C, BRCA1+
Symptoms: Inability to urinate
Treatments: Chemotherapy, de-bulking surgery, total hysterectomy
...
Susan R., High-Grade Serous Ovarian Cancer, Stage 4
Symptoms: Pulling sensation when emptying bladder, abdominal pain
Treatments: Chemotherapy (carboplatin & paclitaxel), surgery
...
Sara I., High-Grade Serous & Clear Cell Carcinoma, Stage 3A
Symptoms: Random sharp pains, unrelated scan showed ovarian cyst
Treatments: Debulking surgery, chemotherapy (carboplatin & paclitaxel), PARP inhibitors (clinical trial)
...